This is a copy of the September 1st edition of our weekly Newsletter, which we have been publishing since October 2015.
Friends,
This week, New Cannabis Ventures celebrated a milestone as we published our 100th industry leadership interview. We began this process just 19 months ago, a little more than 2 years after we launched the platform as another tool to help our audience discover under-the-radar private and public cannabis companies, gain a better understanding of some better known companies and to learn about some of their leading peers or peers of companies in which they invest. View our entire library of interviews.
The overriding goal of New Cannabis Ventures remains to provide a valued service to our readers by filtering a substantial amount of industry news, sharing only what we think our readers will find important and doing so in a timely manner. We supplement this with data-driven resources, such as the popularized public company revenue tracker, industry events, earnings call calendars, IPO and new issues tracker and six professionally managed family of stock indexes, as well as exclusive and original content. Simply put, all our published content is designed to give our readers an edge as they look to invest or operate in the cannabis industry. For investors who want an even bigger edge, we offer a premium service as well.
From a high level perspective, our interviews have been quite diverse, with 49% of the companies privately-held and over 30% from companies operating outside of the U.S. Though our industry struggles with diversity issues, 24% of the interviews we have conducted have been with females and minorities. We are pleased to conduct these interviews at our own expense and for the benefit of our readers.
Many of the companies we have interviewed have found great success subsequently. Our very first interview, with Organigram CEO Greg Engel in early 2018, was quite timely, just three months ahead of an inflection point in the company’s recovery from challenges in early 2017. We published an interview with Paul Benhaim, founder and then CEO of Elixinol Global in May 2018, spotlighting it on a very timely basis when the newly public company was relatively obscure.
Several companies were acquired shortly after we published interviews, including MPX Bioceutical, Hiku Brands, Medically Correct (incredibles), Quadron Cannatech, Origin House (pending), PharmaCann, Emblem, and ebbu, Finally, some of the investors we have profiled, like Merida Capital and Green Acre Capital, have been able to raise and deploy substantial capital. We continue to work hard to serve a professional readership which broadly spans from financial institutions, family offices, municipalities and regulatory authorities, as well as big law, accountancy, advisory, analysts, executives, academics, journalists, entrepreneurs and retail investors.
We are quite proud of the interviews we have shared to date, and we look forward to continuing to spotlight leading operators and investors in our dynamic industry.
As a top ten revenue generating cannabis company operating in the U.S., Cresco Labs is well positioned for the upcoming adult-use implementation in Illinois. Being operational in seven U.S. states, with binding transactions pending in California, New York, Massachusetts and Florida, as well as approved expansion into Michigan, Cresco is moving forward with a new retail cannabis experience with the national rollout of their Sunnyside* dispensaries.
To learn more about Cresco Labs, a client of New Cannabis Ventures, visit the company’s Investor Dashboard that we maintain on its behalf and click the blue Follow Company button in order to stay up to date with their progress.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
-
- Exclusive: After Breakout Quarter, GTI Looks to Scale and Optimize Its 12-State Footprint
- Guest Post: Assessing Different Types of Cannabis License Denial Challenges
- Curaleaf Q2 Revenue Grows 231% to $48.5 Million
- Emerald Health to Sell $25 Million $2 Convertible Notes with 12.5 Million $2 Warrants
- Green Thumb Industries (GTI) Triples Revenue to $44.7 Million and Reports $5.0 Million in Adjusted Operating EBITDA in Second Quarter 2019
- Exclusive: Grenco Science Raises Growth Capital After 8 Years as an Early Mover in Cannabis Vaporization Technology
- Hound Labs Raises $30 Million to Support Commercial Development of Combined Cannabis and Alcohol Breathalyzer
- iAnthus Q2 Revenue Doubles Sequentially to $19.2 Million
- JW Asset Injects $31.5 Million Into TerrAscend Through Warrant Exercise
- Exclusive: Leading Publicly Traded Cannabis Companies Post Strong Revenue Growth in June Quarter
- Origin House Revenue Increases 91% Sequentially to C$21.4 Million
- Planet 13 Nevada Cannabis Sales Grow 275% to $16.5 Million in Second Quarter
- Tilray to Acquire Alberta Cannabis Retailer for $70 Million in Stock with Additional Earnouts
- TILT Holdings Reports Q2 Revenue of $39 Million and Pre-Announces July Revenue of $15 Million
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5M per quarter.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Find your place in the cannabis industry by visiting our Careers and Jobs Page and learn which companies are hiring aggressively.
Sincerely,
Alan & Joel
